[1]
Yin, J. et al. 2023. Immunomodulatory effect of IL-2 induced bone marrow mononuclear cell therapy on control of allergic asthma. Allergologia et Immunopathologia. 51, 1 (Jan. 2023), 110–115. DOI:https://doi.org/10.15586/aei.v51i1.746.